Variant report
Variant | nsv827777 |
---|---|
Chromosome Location | chr16:82872227-82872944 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:1)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:1 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | E2F4 | chr16:82872471-82872619 | MCF10A-Er-Src | breast: | n/a | n/a |
No data |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000221395 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs570223349 | chr16:82872241-82872242 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs532733572 | chr16:82872258-82872259 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs9934411 | chr16:82872292-82872293 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs566342931 | chr16:82872299-82872300 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs9921831 | chr16:82872313-82872314 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs572810167 | chr16:82872315-82872316 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs566941788 | chr16:82872321-82872322 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs34264140 | chr16:82872323-82872324 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs368232318 | chr16:82872348-82872349 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs78186874 | chr16:82872362-82872363 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs555848169 | chr16:82872367-82872368 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs201258417 | chr16:82872372-82872373 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs386793131 | chr16:82872375-82872376 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs2615129 | chr16:82872377-82872378 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs538823089 | chr16:82872410-82872411 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs558498126 | chr16:82872413-82872414 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs572271310 | chr16:82872417-82872418 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs145231292 | chr16:82872418-82872419 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs149138465 | chr16:82872457-82872458 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs574896087 | chr16:82872472-82872473 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs9934566 | chr16:82872483-82872484 | Weak transcription Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs563802145 | chr16:82872484-82872485 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs35361785 | chr16:82872489-82872490 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs11645173 | chr16:82872494-82872495 | Weak transcription Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs142250290 | chr16:82872516-82872517 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs9932406 | chr16:82872522-82872523 | Weak transcription Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs528752493 | chr16:82872525-82872526 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs548474211 | chr16:82872557-82872558 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs182784753 | chr16:82872576-82872577 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs147873690 | chr16:82872580-82872581 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs543241593 | chr16:82872590-82872591 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs9922081 | chr16:82872591-82872592 | Weak transcription Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs187440099 | chr16:82872617-82872618 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs7206608 | chr16:82872628-82872629 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
35 | rs538388648 | chr16:82872629-82872630 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs527992585 | chr16:82872648-82872649 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs558690137 | chr16:82872651-82872652 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs377417885 | chr16:82872678-82872679 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs542246723 | chr16:82872682-82872683 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs142313213 | chr16:82872697-82872698 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs528784752 | chr16:82872719-82872720 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs534875599 | chr16:82872737-82872738 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs370819606 | chr16:82872739-82872740 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs9934819 | chr16:82872778-82872779 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs2061629 | chr16:82872790-82872791 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs111364786 | chr16:82872801-82872802 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs35376052 | chr16:82872807-82872808 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs62035167 | chr16:82872810-82872811 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs577236335 | chr16:82872811-82872812 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs2113137 | chr16:82872814-82872815 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Autism | 19415332 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Schizophrenia | 22958593 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Autism | 22495311 | CNVD |
Wilms tumour | 21544195 | CNVD |
Prostate cancer | 18632612 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16702952 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Prostate cancer | 19242612 | CNVD |
Cancer | 22429812 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Melanoma | 18172304 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 20837533 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Breast cancer | 17001317 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Breast cancer | 17603634 | CNVD |
Prostate cancer | 16573809 | CNVD |
Prostate cancer | 17245344 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Breast cancer | 21806811 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 21509527 | CNVD |
Breast cancer | 21364760 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Autism | 21865298 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 16461572 | CNVD |
Melanoma | 20688739 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Alveolar capillary dysplasia | 19500772 | CNVD |
VACTERL syndrome | 21315191 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Developmental delay | 19490664 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Adrenocortical carcinoma | 18281524 | CNVD |
Autism | 20531469 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr16:82833000-82873600 | Weak transcription | HMEC | breast |
2 | chr16:82848200-82898200 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
3 | chr16:82856800-82876200 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
4 | chr16:82863200-82892800 | Weak transcription | HSMMtube | muscle |
5 | chr16:82866800-82878600 | Weak transcription | Aorta | Aorta |
6 | chr16:82867400-82874600 | Weak transcription | Skeletal Muscle Male | skeletal muscle |
7 | chr16:82868200-82878200 | Weak transcription | Fetal Muscle Trunk | muscle |
8 | chr16:82868400-82874600 | Weak transcription | Left Ventricle | heart |
9 | chr16:82868400-82876000 | Weak transcription | HSMM | muscle |
10 | chr16:82868400-82878800 | Weak transcription | Right Atrium | heart |
11 | chr16:82869400-82878800 | Weak transcription | Right Ventricle | heart |
12 | chr16:82869600-82880000 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
13 | chr16:82872000-82874600 | Weak transcription | Foreskin Keratinocyte Primary Cells skin02 | Skin |
14 | chr16:82872400-82872600 | Enhancers | Psoas Muscle | Psoas |
15 | chr16:82872600-82874600 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |